Palouse Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-51,536
Closed -$3.06M 88
2022
Q1
$3.06M Buy
51,536
+1,303
+3% +$77.5K 1.35% 32
2021
Q4
$3.65M Sell
50,233
-1,078
-2% -$78.3K 1.56% 22
2021
Q3
$3.58M Sell
51,311
-1,296
-2% -$90.5K 1.59% 20
2021
Q2
$3.62M Sell
52,607
-444
-0.8% -$30.6K 1.58% 21
2021
Q1
$3.43M Sell
53,051
-1,602
-3% -$104K 1.51% 28
2020
Q4
$3.18M Sell
54,653
-32,153
-37% -$1.87M 1.69% 24
2020
Q3
$5.49M Buy
86,806
+8,315
+11% +$525K 3.07% 3
2020
Q2
$6.04M Sell
78,491
-3,213
-4% -$247K 3.19% 3
2020
Q1
$6.11M Buy
81,704
+3,623
+5% +$271K 3.61% 2
2019
Q4
$5.07M Sell
78,081
-12,404
-14% -$806K 1.92% 26
2019
Q3
$5.74M Sell
90,485
-1,322
-1% -$83.8K 2.13% 18
2019
Q2
$6.2M Sell
91,807
-1,096
-1% -$74K 2.23% 14
2019
Q1
$6.04M Buy
92,903
+10,619
+13% +$690K 2.32% 12
2018
Q4
$5.15M Sell
82,284
-10,214
-11% -$639K 2.03% 20
2018
Q3
$7.14M Buy
92,498
+456
+0.5% +$35.2K 2.5% 6
2018
Q2
$6.52M Sell
92,042
-1,331
-1% -$94.3K 2.21% 10
2018
Q1
$7.04M Buy
93,373
+302
+0.3% +$22.8K 2.34% 8
2017
Q4
$6.67M Buy
93,071
+511
+0.6% +$36.6K 2.25% 9
2017
Q3
$7.5M Sell
92,560
-783
-0.8% -$63.4K 2.51% 5
2017
Q2
$6.61M Sell
93,343
-392
-0.4% -$27.7K 2.4% 8
2017
Q1
$6.37M Buy
93,735
+52,339
+126% +$3.55M 2.42% 8
2016
Q4
$2.96M Sell
41,396
-5,850
-12% -$419K 1.21% 40
2016
Q3
$3.74M Sell
47,246
-2,948
-6% -$233K 1.59% 27
2016
Q2
$4.19M Buy
50,194
+11,890
+31% +$992K 1.7% 24
2016
Q1
$3.52M Buy
+38,304
New +$3.52M 1.44% 31